New scan could end MS misdiagnosis, spare patients risky drugs

NCT ID NCT04495556

Ongoing Diagnosis Sponsor: The Cleveland Clinic Source: ClinicalTrials.gov ↗

Summary

This study is testing if a specific feature seen on MRI scans, called the 'central vein sign,' can help doctors diagnose Multiple Sclerosis (MS) more accurately and quickly. It involves 420 people in North America who have symptoms that are either typical or not typical for MS. The goal is to see if this sign can reduce misdiagnosis, which currently leads to some people getting powerful MS drugs they don't actually need.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Cedars-Sinai Medical Center

Los Angeles, California, 90048, United States
Cleveland Clinic Foundation

Cleveland, Ohio, 44195, United States
Johns Hopkins University

Baltimore, Maryland, 21218, United States
St. Michael's Hospital of Unity Health Toronto

Toronto, Ontario, M5B1W8, Canada
The University of Texas at Austin

Austin, Texas, 78759, United States
University of Colorado

Aurora, Colorado, 80045, United States
University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States
University of Southern California

Los Angeles, California, 90089, United States
University of Vermont

Burlington, Vermont, 05405, United States
Washington University in St. Louis

St Louis, Missouri, 63130, United States
Yale University

New Haven, Connecticut, 06520, United States

Conditions

Explore the condition pages connected to this study.

MULTIPLE SCLEROSIS